person · Reporting owner
Corroon James Michael Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CV Sciences, Inc.CVSI · Entity 8316 | Director | February 18, 2025 | February 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CV Sciences, Inc.
Report date February 18, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.04 · Expires 2035-02-17 | Direct | 500,000 |
Reported balance
After 2025-02-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-18 · Grant · Acquired 500,000 · Balance 500,000 F1: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2025 Filed Feb 20, 2025 22:28 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0000950170-25-024330 · ownership.xml · derivative · entry 1 Corroon James Michael Jr. · CIK 0001940094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-02-17 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:46 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000950170-24-076934 · ownership.xml · derivative · entry 1 Corroon James Michael Jr. · CIK 0001940094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2034-06-19 F1 · derivative.exercise_date: The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| August 12, 2022 Filed Aug 15, 2022 20:58 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantEmployee Stock Option (right to buy) · Derivative | 500,000 | $0.03 Strike: $0.03 | $16,250.00 |
DisclosureSEC source: 0001510964-22-000070 · wf-form4_166059514822325.xml · derivative · entry 1 Corroon James Michael Jr. · CIK 0001940094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: The option is durational based. Fifty (50%) of the option shares vest and become exercisable on August 12, 2023 and August 12, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.